MEETINGS - Conference on Regulation and Marketing for Self Diagnostic and Home Monitoring Products (UK) June 1997:
This article was originally published in Clinica
SMI will host a conference on Regulation & Marketing for Self Diagnostic & Home Monitoring Products which will be held on 24th-25th June, 1997. Further information can be obtained from: SMI, Number One, New Concordia Wharf, Mill Street, London SE1 2BB. Tel: +44 (171) 252 2222. Fax: +44 (171) 252 2272.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.